Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors

A Coosemans, J Ceusters, C Landolfo, T Baert, W Froyman, R Heremans, G Thirion, S Claes, J Oosterlynck, R Wouters, A Vankerckhoven, F Moro, F Mascilini, A Neumann, AS Van Rompuy, D Schols, J Billen, T Van Gorp, I Vergote, T Bourne, C Van Holsbeke, V Chiappa, G Scambia, A Testa, D Fischerova, D Timmerman, B Van Calster
doi: https://doi.org/10.1101/2024.03.14.24304282

Article Information

doi 
https://doi.org/10.1101/2024.03.14.24304282
History 
  • March 15, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. A Coosemans1,$,#,
  2. J Ceusters1,#,
  3. C Landolfo1,2,3,4,
  4. T Baert5,6,
  5. W Froyman2,5,
  6. R Heremans2,
  7. G Thirion1,
  8. S Claes7,
  9. J Oosterlynck8,
  10. R Wouters1,9,
  11. A Vankerckhoven1,
  12. F Moro4,
  13. F Mascilini4,
  14. A Neumann10,
  15. AS Van Rompuy11,
  16. D Schols7,
  17. J Billen8,
  18. T Van Gorp5,6,
  19. I Vergote5,6,
  20. T Bourne2,3,
  21. C Van Holsbeke12,
  22. V Chiappa13,
  23. G Scambia4,
  24. A Testa2,4,
  25. D Fischerova10,
  26. D Timmerman2,5,* and
  27. B Van Calster2,14,15,*
  1. 1Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
  2. 2Department of Development and Regeneration, KU Leuven, Leuven, Belgium
  3. 3Queen Charlotte’s and Chelsea Hospital, Imperial College, London, UK
  4. 4Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy
  5. 5Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium
  6. 6Department of Oncology, Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
  7. 7Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy (Rega Institute), KU Leuven, Leuven, Belgium
  8. 8Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
  9. 9Oncoinvent AS, Oslo, Norway
  10. 10Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
  11. 11Department of Pathology, University Hospitals Leuven, Leuven, Belgium
  12. 12Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium
  13. 13Department of Gynecologic Oncology, National Cancer Institute of Milan, Milan, Italy
  14. 14Department of Biomedical Data Sciences, Leiden University Medical Centre (LUMC), Leiden, Netherlands
  15. 15Leuven Unit for Health Technology Assessment Research (LUHTAR), KU Leuven, Leuven, Belgium
  1. ↵$Corresponding author: An Coosemans KU Leuven Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy Herestraat 49, box 815 3000 Leuven Belgium 003216340809; an.coosemans{at}kuleuven.be
Back to top
Posted March 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors
A Coosemans, J Ceusters, C Landolfo, T Baert, W Froyman, R Heremans, G Thirion, S Claes, J Oosterlynck, R Wouters, A Vankerckhoven, F Moro, F Mascilini, A Neumann, AS Van Rompuy, D Schols, J Billen, T Van Gorp, I Vergote, T Bourne, C Van Holsbeke, V Chiappa, G Scambia, A Testa, D Fischerova, D Timmerman, B Van Calster
medRxiv 2024.03.14.24304282; doi: https://doi.org/10.1101/2024.03.14.24304282
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area